M1 Kliniken AG

Latest Results (16.09.2025):

M1 Kliniken AG has reported its preliminary consolidated figures for the 2024 financial year, showcasing robust growth across key financial metrics. The company benefited from sustained high demand for beauty treatments and effective implementation of its efficiency strategy, reinforcing its position as a leading provider in the aesthetic medical healthcare sector.

Revenue Growth

Group revenue increased by 7% to €339.2 million compared to €316.3 million in the previous year. The Beauty segment, the main growth driver, saw a 30% rise in revenue to €91.7 million.

Profitability Enhancements

EBIT grew significantly by 70%, reaching €26.8 million from €15.7 million the year before. Earnings per share also saw a substantial increase of 57%, rising to €0.85 from €0.54.

EBITDA and EBIT Margins

EBITDA surged by 52% to €32.0 million, while the EBIT margin in the Beauty segment remained stable at around 22%, reflecting consistent operational efficiency.

Operational Expansion

M1 Kliniken AG expanded its footprint by opening five new clinics in Germany and abroad, bringing the total to 63 clinics across ten countries. This expansion bolsters the company's market leadership in Europe and Australia.

Financial Stability

The equity ratio improved to 71% from 67%, underscoring the company's solid financial stability. Despite a decline in the financial result due to higher interest rates, earnings before taxes rose by 53% to €26.3 million.

Outlook for 2025

M1 Kliniken AG plans to continue its profitable growth by expanding both nationally and internationally. The company targets annual revenues of €200 to €300 million with an EBIT margin of at least 20% within the Beauty segment by 2029.